Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/67564Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Palomer Tarridas, Francesc Xavier | - |
| dc.contributor.author | Barroso Fernández, Emma | - |
| dc.contributor.author | Vázquez Carrera, Manuel | - |
| dc.date.accessioned | 2015-10-30T16:42:02Z | - |
| dc.date.available | 2015-10-30T16:42:02Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/67564 | - |
| dc.description | Podeu consultar el llibre complet a: http://hdl.handle.net/2445/67430 | ca |
| dc.description.abstract | Diabetic cardiomyopathy is characterized by structural and functional alterations in the heart muscle of people with diabetes that finally lead to heart failure. Metabolic disturbances characterized by increased lipid oxidation, intramyocardial triglyceride accumulation and reduced glucose utilization have all been involved in the pathogenesis of diabetic cardiomyopathy. On the other hand, evidences arisen in the recent years point to a potential link between chronic low-grade inflammation in the heart and metabolic dysregulation. Interestingly, the progression of heart failure and cardiac hypertrophy usually entails the activation of pro-inflammatory pathways. Therefore, in this chapter we summarize novel insights into the crosstalk between inflammatory processes and metabolic dysregulation in the failing heart during diabetes. | ca |
| dc.format.extent | 20 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | ca |
| dc.publisher | Research Signpost | ca |
| dc.relation.isformatof | Reproducció del capítol del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=249 | - |
| dc.relation.ispartof | Recent Advances in Pharmaceutical Sciences V, 2015, Research Signpost. Editors: Diego Muñoz Torrero, M. Pilar Vinardell & Javier Palazón. ISBN: 978-81-308-0561-0. Chapter 11, p. 167-186. | - |
| dc.relation.uri | http://hdl.handle.net/2445/67430 | - |
| dc.rights | (c) Research Signpost, 2015 | - |
| dc.source | Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica) | - |
| dc.subject.classification | Complicacions de la diabetis | cat |
| dc.subject.classification | Miocardiopaties | cat |
| dc.subject.classification | Farmacologia | cat |
| dc.subject.other | Diabetes complications | eng |
| dc.subject.other | Myocardiopathies | eng |
| dc.subject.other | Pharmacology | - |
| dc.title | Inflammation and metabolic dysregulation in diabetic cardiomyopathy | eng |
| dc.type | info:eu-repo/semantics/bookPart | ca |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.identifier.idgrec | 293091 | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
| Appears in Collections: | Llibres / Capítols de llibre (Institut de Biomedicina (IBUB)) Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| T_1444299910Munozv 11.pdf | 772.89 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.